CHRYSTAL MEANS: Open Payments
NPI 1497710180 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,696 in 86 payments from 25 companies in 2025. Trend: 2023 $1,786 · 2024 $2,673 · 2025 $1,696
Food & beverage: $1,696
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $321 |
| Novo Nordisk Inc | 11 | $228 |
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| PFIZER INC. | 6 | $110 |
| Lilly USA, LLC | 5 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Verona Pharma, Inc. | 3 | $77 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Edwards Lifesciences Corporation | 2 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
Products named: QULIPTA, AIRSUPRA, VRAYLAR, Ozempic, CAPLYTA, Rybelsus, Ohtuvayre, PREVNAR 20.
Industry payments across KY — which companies pay providers there.
